EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudie

A Risk Prediction Model for the Development of Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Sclerosis in Patients With Systemic Lupus Erythematosus: Multicenter Approaches

Rui-Cen Li, Wang-Dong Xu iD, Xiao-Yan Liu, Lu Fu, You-Yu Lan, Si-Yu Feng, An-Fang Huang iD

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70156 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Rui-Cen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Scleroderma, Systemic, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: the Sichuan Provincial Natural Science Foundation, Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Project Fund, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of this study was to construct a predictive model to evaluate the risk of overlapping syndrome (OS), including the combination of systemic sclerosis, rheumatoid arthritis, and Sjögren's syndrome in patients with systemic lupus erythematosus (SLE) from multicenters.

Methods

This study included SLE patients in the development cohort ( n = 4714) and the external validation cohort ( n = 2271). SLE patients in the development cohort were randomly divided into the training cohort and the internal validation cohort at a 7:3 ratio. Laboratory variables were collected and compared by univariate logistic regression modeling. Multivariate logistic regression was further used to develop predictive models and plot a risk nomogram for OS. Receiver operating characteristic (ROC) and calibration curve analysis were used to assess model validity and accuracy. Decision curve analysis was used to assess net clinical benefit.

Results

Indexes including anti‐SSA antibody, anti‐SSB antibody, proteinuria, occult blood in urine, age, eosinophil ratio, hematocrit, platelet, direct bilirubin, indirect bilirubin, rheumatoid factor, immunoglobulin A, prothrombin time, and ferritin were included in the predictive model. The nomogram showed a wide range of predictive ability. The area under the curve (AUC) of the ROC curve for the training cohort was 0.874 (0.851–0.896), the AUC for the internal validation cohort was 0.877 (0.843–0.911), and the AUC for the external validation cohort was 0.760 (0.730–0.790).

Conclusion

The model has a good predictive performance and will be clinically valuable for the assessment of the risk of OS in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeScleroderma, SystemicLupus Erythematosus, SystemicArthritis, RheumatoidNomogramsDecision Support TechniquesHumansFemaleMaleRisk AssessmentRisk FactorsMiddle AgedAdultPredictive Value of TestsReproducibility of ResultsPrognosisRetrospective StudiesBiomarkers

Stichwörter der Autor:innen

overlapping syndromepredictionrisksystemic lupus erythematosus

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Evidence-Based Medicine, School of Public Health, Southwest Medical University, Luzhou, Sichuan, China.
  • Laboratory Animal Center, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Rheumatology and Immunology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.

ORCID-Profile: Wang-Dong Xu, An-Fang Huang

Förderung

  • the Sichuan Provincial Natural Science Foundation
  • Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Project Fund
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Li, R. C., Xu, W. D., Liu, X. Y., Fu, L., Lan, Y. Y., Feng, S. Y., & Huang, A. F. (2025). A Risk Prediction Model for the Development of Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Sclerosis in Patients With Systemic Lupus Erythematosus: Multicenter Approaches. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70156

Vancouver

Li RC, Xu WD, Liu XY, Fu L, Lan YY, Feng SY, et al. A Risk Prediction Model for the Development of Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Sclerosis in Patients With Systemic Lupus Erythematosus: Multicenter Approaches. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70156

BibTeX
@article{Li2025,
  author = {Li, Rui-Cen and Xu, Wang-Dong and Liu, Xiao-Yan and Fu, Lu and Lan, You-Yu and Feng, Si-Yu and Huang, An-Fang},
  title = {A Risk Prediction Model for the Development of Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Sclerosis in Patients With Systemic Lupus Erythematosus: Multicenter Approaches},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70156}
}
Kostenlos starten →